logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12605485 B1

PDFFull Text
Date of Patent:
Apr. 21, 2026

Filed:

Oct. 26, 2022

Nanoparticles to promote wound healing and antimicrobial infection control

Applicant:

Kismet Technologies Llc, Winter Park, FL (US);

Inventor:

Christina H. Drake, Winter Park, FL (US);

Assignee:

Kismet Technologies Inc., Orlando, FL (US);

Attorneys:

Terry M. Sanks, Esq.

Beusse Sanks, PLLC

Primary Examiner:

Mark V Stevens

Int. Cl.
CPC ...
A61L 26/00 (2006.01); A61K 9/14 (2006.01); A61K 33/00 (2006.01); A61K 33/24 (2019.01); A61K 33/242 (2019.01); A61K 33/243 (2019.01); A61K 33/26 (2006.01); A61K 33/30 (2006.01); A61K 33/34 (2006.01); A61K 33/38 (2006.01); A61K 38/19 (2006.01); A61K 47/10 (2017.01); A61K 47/34 (2017.01); A61K 47/36 (2006.01); A61K 47/42 (2017.01); A61K 48/00 (2006.01); A61P 27/02 (2006.01);
U.S. Cl.
CPC ...
A61L 26/0066 (2013.01); A61K 9/14 (2013.01); A61K 33/00 (2013.01); A61K 33/24 (2013.01); A61K 33/242 (2019.01); A61K 33/243 (2019.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 33/34 (2013.01); A61K 33/38 (2013.01); A61K 38/19 (2013.01); A61K 47/10 (2013.01); A61K 47/34 (2013.01); A61K 47/36 (2013.01); A61K 47/42 (2013.01); A61L 26/0095 (2013.01); A61P 27/02 (2018.01); A61K 48/00 (2013.01); A61L 2300/104 (2013.01); A61L 2300/402 (2013.01); A61L 2300/404 (2013.01); A61L 2300/41 (2013.01); A61L 2400/12 (2013.01);
Abstract

A wound healing composition is provided that includes a tissue adhesive or epithelial tissue healing agent and metal-modified cerium oxide nanoparticles (mCNPs). The nCNPs have a predominant 3+ surface charge and are in a range of about 3-35 nanometers (nm) in size and mixed in an amount that is in a range of about 0.01 to 0.1 weight percentage of a mixture having the tissue adhesive or epithelial tissue healing agent and the mCNPs. The metal (m) is a stable metallic metal with antimicrobial properties and non-ionizing. The mCNPs includes AgCNP2. A method is provided that uses the healing composition to treat a wound or epithelial tissue. The composition can be used to treat the skin or eye and/or subcutaneous tissue.

Find Patent Forward Citations

Loading…